Target Gene Table ▼
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30004953HIVENSG00000105953.16protein_codingOGDHNoNo4967E9PCR7
Q02218
TVIS30014133HIVENSG00000105953.16protein_codingOGDHNoNo4967E9PCR7
Q02218
TVIS30009304HIVENSG00000105953.16protein_codingOGDHNoNo4967E9PCR7
Q02218
TVIS30003985HIVENSG00000105953.16protein_codingOGDHNoNo4967E9PCR7
Q02218
TVIS30009305HIVENSG00000105953.16protein_codingOGDHNoNo4967E9PCR7
Q02218
TVIS30013536HIVENSG00000105953.16protein_codingOGDHNoNo4967E9PCR7
Q02218
TVIS30009306HIVENSG00000105953.16protein_codingOGDHNoNo4967E9PCR7
Q02218
TVIS30017291HIVENSG00000105953.16protein_codingOGDHNoNo4967E9PCR7
Q02218
TVIS30019210HIVENSG00000105953.16protein_codingOGDHNoNo4967E9PCR7
Q02218
TVIS30086988HIVENSG00000105953.16protein_codingOGDHNoNo4967E9PCR7
Q02218
TCGA Plot Options ▼
Drug Information ▼
GeneOGDH
DrugBank IDDB00157
Drug NameNADH
Target IDBE0000162
UniProt IDQ02218
Regulation Type
PubMed IDs17668068
CitationsMailloux RJ, Beriault R, Lemire J, Singh R, Chenier DR, Hamel RD, Appanna VD: The tricarboxylic acid cycle, an ancient metabolic network with a novel twist. PLoS One. 2007 Aug 1;2(8):e690.
GroupsApproved; Nutraceutical
Direct Classification(5'->5')-dinucleotides
SMILESNC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
PathwaysEthylmalonic Encephalopathy; 3-Methylglutaconic Aciduria Type III; Short-Chain Acyl-CoA Dehydrogenase Deficiency (SCAD Deficiency); Caffeine Metabolism; Fructose and Mannose Degradation; Isovaleric Aciduria; Lysine Degradation; Methylmalonic Aciduria Due to Cobalamin-Related Disorders; Glycerol Phosphate Shuttle; Zellweger Syndrome; Propionic Acidemia; Glycolysis; Xanthine Dehydrogenase Deficiency (Xanthinuria); S-Adenosylhomocysteine (SAH) Hydrolase Deficiency; Tryptophan Metabolism; Glutaric Aciduria Type I; 3-Methylcrotonyl-CoA Carboxylase Deficiency Type I; Glycine N-Methyltransferase Deficiency; Dimethylglycine Dehydrogenase Deficiency; Androgen and Estrogen Metabolism; Nucleotide Sugars Metabolism; 3-Methylglutaconic Aciduria Type IV; Dihydropyrimidine Dehydrogenase Deficiency (DHPD); Malate-Aspartate Shuttle; Folate Metabolism; Valine, Leucine, and Isoleucine Degradation; Maple Syrup Urine Disease; Glycerol Kinase Deficiency; Adenylosuccinate Lyase Deficiency; Cysteine Metabolism
PharmGKBPA164755085
ChEMBLCHEMBL1234616